Novel PET imaging methods for prostate cancer.
World J Urol
; 39(3): 687-699, 2021 Mar.
Article
em En
| MEDLINE
| ID: mdl-32671604
ABSTRACT
INTRODUCTION:
Prostate cancer is a common neoplasm but conventional imaging methods such as CT and bone scan are often insensitive. A new class of PET agents have emerged to diagnose and manage prostate cancer.METHODS:
The relevant literature on PET imaging agents for prostate cancer was reviewed.RESULTS:
This review shows a broad range of PET imaging agents, the most successful of which is prostate specific membrane antigen (PSMA) PET. Other agents either lack the sensitivity or specificity of PSMA PET.CONCLUSION:
Among the available PET agents for prostate cancer, PSMA PET has emerged as the leader. It is likely to have great impact on the diagnosis, staging and management of prostate cancer patients.Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Neoplasias da Próstata
/
Tomografia por Emissão de Pósitrons
Limite:
Humans
/
Male
Idioma:
En
Revista:
World J Urol
Ano de publicação:
2021
Tipo de documento:
Article
País de afiliação:
Estados Unidos